Improved Efficacy of Selective Laser Trabeculoplasty With the Addition of Rocklatan Post-treatment vs Artificial Tears Post-treatment

RecruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

February 14, 2025

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions

Glaucoma

Interventions

DRUG

Rocklatan

netarsudil and latanoprost ophthalmic solution 0.02%/0.005%

DRUG

Systane Ultra

artificial tears

Trial Locations (1)

RECRUITING

Colorado Ophthalmology Associates PC, Denver

All Listed Sponsors

collaborator

Sengi

INDUSTRY

lead

Colorado Ophthalmology Associates PC

OTHER